Title : BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

Pub. Date : 2015 Jan 13

PMID : 25583261






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Paclitaxel BRCA1 DNA repair associated Homo sapiens
2 Here we investigate the role of BRCA1-IRIS as a novel treatment target for TNBCs and their paclitaxel-resistant recurrences. Paclitaxel BRCA1 DNA repair associated Homo sapiens
3 METHODS: We analyzed the response of BRCA1-IRIS overexpressing normal mammary cells or established TNBC cells silenced from BRCA1-IRIS to paclitaxel in vitro and in vivo. Paclitaxel BRCA1 DNA repair associated Homo sapiens
4 We analyzed BRCA1-IRIS downstream signaling pathways in relation to paclitaxel treatment. Paclitaxel BRCA1 DNA repair associated Homo sapiens
5 RESULTS: We show that low concentrations of paclitaxel triggers BRCA1-IRIS expression in vitro and in vivo, and that BRCA1-IRIS activates two autocrine signaling loops (epidermal growth factor (EGF)/EGF receptor 1 (EGFR)-EGF receptor 2 (ErbB2) and neurogulin 1 (NRG1)/ErbB2-EGF receptor 3 (ErbB3), which enhances protein kinase B (AKT) and thus survivin expression/activation through promoting FOXO3a degradation. Paclitaxel BRCA1 DNA repair associated Homo sapiens
6 These events trigger the intrinsic and acquired paclitaxel resistance phenotype known for BRCA1-IRIS-overexpressing TNBCs. Paclitaxel BRCA1 DNA repair associated Homo sapiens
7 Inactivating BRCA1-IRIS signaling using a novel inhibitory mimetic peptide inactivates these autocrine loops, AKT and survivin activity/expression, in part by restoring FOXO3a expression, and sensitizes TNBC cells to low paclitaxel concentrations in vitro and in vivo. Paclitaxel BRCA1 DNA repair associated Homo sapiens
8 CONCLUSIONS: In addition to driving TNBC tumor formation, BRCA1-IRIS overexpression drives their intrinsic and acquired paclitaxel resistance, partly by activating autocrine signaling loops EGF/EGFR-ErbB2 and NRG1/ErbB2-ErbB3. Paclitaxel BRCA1 DNA repair associated Homo sapiens